Tempus AI (NASDAQ:TEM) Trading Up 1.6% – Still a Buy?

Tempus AI, Inc. (NASDAQ:TEM) shares traded up 1.6% on Monday . The company traded as high as $71.23 and last traded at $70.09. 8,219,791 shares traded hands during mid-day trading, a decline of 29% from the average session volume of 11,580,188 shares. The stock had previously closed at $68.96.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on TEM. TD Cowen reaffirmed a “buy” rating and issued a $74.00 target price (up from $58.00) on shares of Tempus AI in a report on Wednesday, February 5th. Loop Capital cut their target price on Tempus AI from $57.00 to $52.00 and set a “buy” rating on the stock in a research note on Tuesday, January 14th. Guggenheim began coverage on Tempus AI in a research note on Monday, December 9th. They issued a “buy” rating and a $74.00 price target for the company. Needham & Company LLC reaffirmed a “buy” rating and set a $56.00 price objective on shares of Tempus AI in a research report on Tuesday, January 14th. Finally, William Blair lowered Tempus AI from an “outperform” rating to a “market perform” rating in a research report on Wednesday. Four research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $58.55.

Tempus AI Stock Performance

The company has a current ratio of 2.69, a quick ratio of 2.55 and a debt-to-equity ratio of 8.17. The company has a fifty day moving average price of $44.89 and a 200-day moving average price of $49.56.

Insider Activity at Tempus AI

In other news, CAO Ryan M. Bartolucci sold 13,770 shares of the company’s stock in a transaction that occurred on Friday, January 31st. The stock was sold at an average price of $60.00, for a total transaction of $826,200.00. Following the transaction, the chief accounting officer now owns 57,237 shares of the company’s stock, valued at approximately $3,434,220. This represents a 19.39 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO Eric P. Lefkofsky sold 187,655 shares of the business’s stock in a transaction on Wednesday, December 18th. The shares were sold at an average price of $37.54, for a total value of $7,044,568.70. Following the transaction, the chief executive officer now owns 9,557,283 shares of the company’s stock, valued at approximately $358,780,403.82. The trade was a 1.93 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 2,229,449 shares of company stock worth $102,293,124.

Institutional Investors Weigh In On Tempus AI

Several hedge funds have recently made changes to their positions in the company. ARK Investment Management LLC boosted its stake in shares of Tempus AI by 132.1% during the fourth quarter. ARK Investment Management LLC now owns 5,519,644 shares of the company’s stock valued at $186,343,000 after purchasing an additional 3,141,487 shares in the last quarter. Sumitomo Mitsui Trust Group Inc. lifted its holdings in Tempus AI by 166.0% during the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,239,093 shares of the company’s stock worth $109,352,000 after buying an additional 2,021,394 shares during the period. Nikko Asset Management Americas Inc. boosted its position in Tempus AI by 166.0% during the 4th quarter. Nikko Asset Management Americas Inc. now owns 3,239,093 shares of the company’s stock valued at $109,352,000 after acquiring an additional 2,021,394 shares in the last quarter. Franklin Resources Inc. increased its holdings in shares of Tempus AI by 240.5% in the 4th quarter. Franklin Resources Inc. now owns 2,762,173 shares of the company’s stock valued at $93,251,000 after acquiring an additional 1,950,862 shares during the period. Finally, JPMorgan Chase & Co. raised its position in shares of Tempus AI by 86,947.2% in the 4th quarter. JPMorgan Chase & Co. now owns 1,653,896 shares of the company’s stock worth $55,836,000 after acquiring an additional 1,651,996 shares in the last quarter. 24.22% of the stock is currently owned by hedge funds and other institutional investors.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.